LOS ANGELES, Oct. 30 /PRNewswire/ -- Elekta, a pioneer in the field of stereotactic radiosurgery, currently is showcasing the broadest portfolio of stereotactic technology in the industry at the 49th Annual Meeting of The American Society for Therapeutic Radiology and Oncology (ASTRO). Held October 28-November 1 at the Los Angeles Convention Center, ASTRO is the perfect forum for Elekta to showcase its latest products covering the full spectrum of stereotactic systems and solutions for planning, immobilization, treatment and post-processing.
"No other vendor has the breadth of solutions that Elekta offers its users," says Tomas Puusepp, Elekta President and CEO. "We provide innovations through the continuum of care that help fight serious disease and improve quality of life for patients."
Of the many programs that have acquired or plan to acquire a new linear accelerator within the next few years, the majority are adding radiosurgery capabilities. With its broad portfolio of solutions, Elekta is uniquely positioned to offer cancer programs the solutions they deem best for delivering radiosurgery.
Leksell Gamma Knife(R) Perfexion(TM) offers state-of-the-art radiosurgery with expanded treatment reach
The newest generation Leksell Gamma Knife(R) is Leksell Gamma Knife(R)
Perfexion(TM). Leksell Gamma Knife is the only radiation therapy device
cleared by the FDA for the treatment of brain metastases. Brain metastases,
tumors originating from cancer in other parts of the body, have been
increasing in incidence worldwide, and traditional treatments for these
tumors often involve a long period of recovery, as well as side effects
like nausea, vomiting and hair loss. Stereotactic radiosurgery with Leksell
Gamma Knife Perfexion offers dramatic improvements in quality of life for
|SOURCE Elekta, Inc.|
Copyright©2007 PR Newswire.
All rights reserved